Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO31451 | Aspergillus sydowii | Species | Aspergillaceae | Eukaryota |
PMID[23647825] |
|||
NPO32607 | penicillium aculeatum sd-321 | Species | Aspergillaceae | Eukaryota |
PMID[25763602] |
|||
NPO31451 | Aspergillus sydowii | Species | Aspergillaceae | Eukaryota |
PMID[21718031] |
|||
NPO31572 | Aspergillus sp. | Species | Aspergillaceae | Eukaryota |
PMID[21718031] |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Inhibition | = | 2.56 | % | 23647825 | |
NPT2 | Others | Unspecified | IC50 | > | 10 | ug/ml | 23647825 | |
NPT2 | Others | Unspecified | Inhibition | = | 60.18 | % | 23647825 | |
NPT2 | Others | Unspecified | IC50 | = | 27820 | nM | 23647825 | |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | 381.4 | mg/dl | 23647825 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | > | 32 | ug/ml | 25763602 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 32 | ug/ml | 25763602 |
NPT1843 | Organism | Aeromonas hydrophila | Aeromonas hydrophila | MIC | > | 32 | ug/ml | 25763602 |
NPT1844 | Organism | Edwardsiella tarda | Edwardsiella tarda | MIC | = | 32 | ug/ml | 25763602 |
NPT729 | Organism | Micrococcus luteus | Micrococcus luteus | MIC | > | 32 | ug/ml | 25763602 |
NPT18 | Organism | Pseudomonas aeruginosa | Pseudomonas aeruginosa | MIC | > | 32 | ug/ml | 25763602 |
NPT1845 | Organism | Vibrio alginolyticus | Vibrio alginolyticus | MIC | > | 32 | ug/ml | 25763602 |
NPT1311 | Organism | Listonella anguillarum | Listonella anguillarum | MIC | = | 32 | ug/ml | 25763602 |
NPT1726 | Organism | Vibrio harveyi | Vibrio harveyi | MIC | = | 4 | ug/ml | 25763602 |
NPT565 | Organism | Vibrio parahaemolyticus | Vibrio parahaemolyticus | MIC | = | 4 | ug/ml | 25763602 |
NPT1846 | Organism | Alternaria brassicae | Alternaria brassicae | MIC | > | 32 | ug/ml | 25763602 |
NPT562 | Organism | Colletotrichum gloeosporioides | Colletotrichum gloeosporioides | MIC | = | 32 | ug/ml | 25763602 |
NPT1847 | Organism | Gaeumannomyces graminis | Gaeumannomyces graminis | MIC | = | 0.5 | ug/ml | 25763602 |
NPT176 | Organism | Artemia salina | Artemia salina | LD50 | > | 10 | ug/ml | 25763602 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC25168 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9912 | High Similarity | NPC165197 |
0.9744 | High Similarity | NPC117794 |
0.9741 | High Similarity | NPC297193 |
0.9661 | High Similarity | NPC472592 |
0.9561 | High Similarity | NPC160199 |
0.9048 | High Similarity | NPC472591 |
0.9008 | High Similarity | NPC275145 |
0.8852 | High Similarity | NPC477153 |
0.876 | High Similarity | NPC159760 |
0.876 | High Similarity | NPC179092 |
0.876 | High Similarity | NPC35856 |
0.876 | High Similarity | NPC178395 |
0.876 | High Similarity | NPC301987 |
0.876 | High Similarity | NPC222876 |
0.876 | High Similarity | NPC244994 |
0.876 | High Similarity | NPC272454 |
0.876 | High Similarity | NPC115188 |
0.876 | High Similarity | NPC26433 |
0.876 | High Similarity | NPC292665 |
0.875 | High Similarity | NPC233165 |
0.875 | High Similarity | NPC184579 |
0.8739 | High Similarity | NPC125252 |
0.8729 | High Similarity | NPC161304 |
0.872 | High Similarity | NPC209959 |
0.8661 | High Similarity | NPC31539 |
0.8655 | High Similarity | NPC312800 |
0.8596 | High Similarity | NPC187913 |
0.8595 | High Similarity | NPC472593 |
0.856 | High Similarity | NPC240744 |
0.856 | High Similarity | NPC287473 |
0.856 | High Similarity | NPC167055 |
0.8547 | High Similarity | NPC228609 |
0.8522 | High Similarity | NPC34715 |
0.8512 | High Similarity | NPC41567 |
0.8487 | Intermediate Similarity | NPC81808 |
0.848 | Intermediate Similarity | NPC236189 |
0.8473 | Intermediate Similarity | NPC161632 |
0.8468 | Intermediate Similarity | NPC325301 |
0.8468 | Intermediate Similarity | NPC283514 |
0.8468 | Intermediate Similarity | NPC46634 |
0.8468 | Intermediate Similarity | NPC244351 |
0.8468 | Intermediate Similarity | NPC327070 |
0.8443 | Intermediate Similarity | NPC160235 |
0.843 | Intermediate Similarity | NPC269414 |
0.8417 | Intermediate Similarity | NPC240163 |
0.8403 | Intermediate Similarity | NPC98543 |
0.8403 | Intermediate Similarity | NPC211421 |
0.8387 | Intermediate Similarity | NPC198336 |
0.8374 | Intermediate Similarity | NPC328485 |
0.8374 | Intermediate Similarity | NPC260837 |
0.8347 | Intermediate Similarity | NPC477453 |
0.8346 | Intermediate Similarity | NPC306765 |
0.8333 | Intermediate Similarity | NPC13426 |
0.8333 | Intermediate Similarity | NPC229638 |
0.8333 | Intermediate Similarity | NPC267539 |
0.8333 | Intermediate Similarity | NPC41851 |
0.8333 | Intermediate Similarity | NPC176102 |
0.8333 | Intermediate Similarity | NPC204257 |
0.8333 | Intermediate Similarity | NPC114918 |
0.8333 | Intermediate Similarity | NPC71108 |
0.8333 | Intermediate Similarity | NPC254832 |
0.8333 | Intermediate Similarity | NPC29317 |
0.8333 | Intermediate Similarity | NPC197513 |
0.832 | Intermediate Similarity | NPC282577 |
0.832 | Intermediate Similarity | NPC307174 |
0.8308 | Intermediate Similarity | NPC7012 |
0.8306 | Intermediate Similarity | NPC164852 |
0.8295 | Intermediate Similarity | NPC109123 |
0.8291 | Intermediate Similarity | NPC100551 |
0.8281 | Intermediate Similarity | NPC71525 |
0.8268 | Intermediate Similarity | NPC123506 |
0.8258 | Intermediate Similarity | NPC474394 |
0.825 | Intermediate Similarity | NPC190212 |
0.8246 | Intermediate Similarity | NPC304873 |
0.8231 | Intermediate Similarity | NPC17840 |
0.8231 | Intermediate Similarity | NPC247477 |
0.8231 | Intermediate Similarity | NPC108129 |
0.8226 | Intermediate Similarity | NPC206778 |
0.8226 | Intermediate Similarity | NPC72977 |
0.8226 | Intermediate Similarity | NPC285829 |
0.8217 | Intermediate Similarity | NPC48248 |
0.8217 | Intermediate Similarity | NPC95537 |
0.8211 | Intermediate Similarity | NPC474890 |
0.8211 | Intermediate Similarity | NPC161943 |
0.8211 | Intermediate Similarity | NPC273282 |
0.8205 | Intermediate Similarity | NPC66834 |
0.8203 | Intermediate Similarity | NPC227741 |
0.8203 | Intermediate Similarity | NPC295202 |
0.8203 | Intermediate Similarity | NPC49647 |
0.8203 | Intermediate Similarity | NPC3224 |
0.8203 | Intermediate Similarity | NPC136342 |
0.8197 | Intermediate Similarity | NPC128825 |
0.8195 | Intermediate Similarity | NPC290803 |
0.8189 | Intermediate Similarity | NPC265910 |
0.8189 | Intermediate Similarity | NPC91475 |
0.8189 | Intermediate Similarity | NPC74507 |
0.8189 | Intermediate Similarity | NPC234890 |
0.8189 | Intermediate Similarity | NPC310540 |
0.8182 | Intermediate Similarity | NPC295406 |
0.8182 | Intermediate Similarity | NPC200422 |
0.8182 | Intermediate Similarity | NPC289572 |
0.8182 | Intermediate Similarity | NPC37299 |
0.8182 | Intermediate Similarity | NPC180261 |
0.8182 | Intermediate Similarity | NPC157478 |
0.8182 | Intermediate Similarity | NPC186933 |
0.8175 | Intermediate Similarity | NPC217756 |
0.8167 | Intermediate Similarity | NPC26615 |
0.816 | Intermediate Similarity | NPC241001 |
0.8158 | Intermediate Similarity | NPC72729 |
0.8154 | Intermediate Similarity | NPC303910 |
0.8148 | Intermediate Similarity | NPC4214 |
0.8145 | Intermediate Similarity | NPC90522 |
0.8145 | Intermediate Similarity | NPC328459 |
0.8136 | Intermediate Similarity | NPC224584 |
0.8134 | Intermediate Similarity | NPC475955 |
0.8134 | Intermediate Similarity | NPC474726 |
0.8134 | Intermediate Similarity | NPC472308 |
0.8134 | Intermediate Similarity | NPC118919 |
0.813 | Intermediate Similarity | NPC240664 |
0.8125 | Intermediate Similarity | NPC201728 |
0.8125 | Intermediate Similarity | NPC262671 |
0.8125 | Intermediate Similarity | NPC131799 |
0.812 | Intermediate Similarity | NPC202225 |
0.812 | Intermediate Similarity | NPC288089 |
0.811 | Intermediate Similarity | NPC273683 |
0.811 | Intermediate Similarity | NPC375356 |
0.8103 | Intermediate Similarity | NPC93831 |
0.8102 | Intermediate Similarity | NPC257003 |
0.8099 | Intermediate Similarity | NPC242136 |
0.8087 | Intermediate Similarity | NPC25458 |
0.808 | Intermediate Similarity | NPC478121 |
0.8077 | Intermediate Similarity | NPC282923 |
0.8077 | Intermediate Similarity | NPC96024 |
0.8074 | Intermediate Similarity | NPC471452 |
0.807 | Intermediate Similarity | NPC217621 |
0.8067 | Intermediate Similarity | NPC95172 |
0.8065 | Intermediate Similarity | NPC328694 |
0.8065 | Intermediate Similarity | NPC94637 |
0.8062 | Intermediate Similarity | NPC160499 |
0.8062 | Intermediate Similarity | NPC231774 |
0.8062 | Intermediate Similarity | NPC96915 |
0.8062 | Intermediate Similarity | NPC473751 |
0.8051 | Intermediate Similarity | NPC141523 |
0.8049 | Intermediate Similarity | NPC83718 |
0.8049 | Intermediate Similarity | NPC108288 |
0.8047 | Intermediate Similarity | NPC68756 |
0.8047 | Intermediate Similarity | NPC152525 |
0.8047 | Intermediate Similarity | NPC199273 |
0.8047 | Intermediate Similarity | NPC142956 |
0.8045 | Intermediate Similarity | NPC263817 |
0.8045 | Intermediate Similarity | NPC43627 |
0.8045 | Intermediate Similarity | NPC48036 |
0.8045 | Intermediate Similarity | NPC115458 |
0.8031 | Intermediate Similarity | NPC300274 |
0.8031 | Intermediate Similarity | NPC475192 |
0.8031 | Intermediate Similarity | NPC121168 |
0.8031 | Intermediate Similarity | NPC68167 |
0.8031 | Intermediate Similarity | NPC132518 |
0.8031 | Intermediate Similarity | NPC477151 |
0.803 | Intermediate Similarity | NPC205992 |
0.803 | Intermediate Similarity | NPC93015 |
0.8029 | Intermediate Similarity | NPC147542 |
0.8029 | Intermediate Similarity | NPC32749 |
0.8029 | Intermediate Similarity | NPC327916 |
0.8029 | Intermediate Similarity | NPC183345 |
0.8029 | Intermediate Similarity | NPC42262 |
0.8029 | Intermediate Similarity | NPC37992 |
0.8029 | Intermediate Similarity | NPC225243 |
0.8029 | Intermediate Similarity | NPC241349 |
0.8029 | Intermediate Similarity | NPC220496 |
0.8017 | Intermediate Similarity | NPC231717 |
0.8016 | Intermediate Similarity | NPC190971 |
0.8015 | Intermediate Similarity | NPC117899 |
0.8015 | Intermediate Similarity | NPC34414 |
0.8015 | Intermediate Similarity | NPC146647 |
0.8 | Intermediate Similarity | NPC471530 |
0.8 | Intermediate Similarity | NPC232178 |
0.8 | Intermediate Similarity | NPC272268 |
0.8 | Intermediate Similarity | NPC181715 |
0.8 | Intermediate Similarity | NPC72667 |
0.8 | Intermediate Similarity | NPC473767 |
0.8 | Intermediate Similarity | NPC176130 |
0.8 | Intermediate Similarity | NPC84672 |
0.8 | Intermediate Similarity | NPC78364 |
0.8 | Intermediate Similarity | NPC69424 |
0.7985 | Intermediate Similarity | NPC204582 |
0.7985 | Intermediate Similarity | NPC474097 |
0.7984 | Intermediate Similarity | NPC76308 |
0.7984 | Intermediate Similarity | NPC325295 |
0.7984 | Intermediate Similarity | NPC103540 |
0.7984 | Intermediate Similarity | NPC121259 |
0.7982 | Intermediate Similarity | NPC6597 |
0.7982 | Intermediate Similarity | NPC79241 |
0.797 | Intermediate Similarity | NPC470160 |
0.797 | Intermediate Similarity | NPC110609 |
0.797 | Intermediate Similarity | NPC246693 |
0.797 | Intermediate Similarity | NPC242358 |
0.797 | Intermediate Similarity | NPC58685 |
0.7969 | Intermediate Similarity | NPC477152 |
0.7969 | Intermediate Similarity | NPC135062 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC25168 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8291 | Intermediate Similarity | NPD74 | Approved |
0.8291 | Intermediate Similarity | NPD9266 | Approved |
0.8205 | Intermediate Similarity | NPD9267 | Approved |
0.8205 | Intermediate Similarity | NPD9263 | Approved |
0.8205 | Intermediate Similarity | NPD9264 | Approved |
0.8197 | Intermediate Similarity | NPD9493 | Approved |
0.8049 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7984 | Intermediate Similarity | NPD1164 | Approved |
0.7984 | Intermediate Similarity | NPD1470 | Approved |
0.7941 | Intermediate Similarity | NPD5405 | Approved |
0.7941 | Intermediate Similarity | NPD2935 | Discontinued |
0.7941 | Intermediate Similarity | NPD5406 | Approved |
0.7941 | Intermediate Similarity | NPD5404 | Approved |
0.7941 | Intermediate Similarity | NPD5408 | Approved |
0.7895 | Intermediate Similarity | NPD288 | Approved |
0.7886 | Intermediate Similarity | NPD9281 | Approved |
0.7863 | Intermediate Similarity | NPD9261 | Approved |
0.782 | Intermediate Similarity | NPD411 | Approved |
0.7812 | Intermediate Similarity | NPD1201 | Approved |
0.7807 | Intermediate Similarity | NPD844 | Approved |
0.7778 | Intermediate Similarity | NPD447 | Suspended |
0.7752 | Intermediate Similarity | NPD9717 | Approved |
0.7752 | Intermediate Similarity | NPD9269 | Phase 2 |
0.775 | Intermediate Similarity | NPD9265 | Clinical (unspecified phase) |
0.7737 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7737 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7717 | Intermediate Similarity | NPD9268 | Approved |
0.7714 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7626 | Intermediate Similarity | NPD2346 | Discontinued |
0.7623 | Intermediate Similarity | NPD4750 | Phase 3 |
0.7578 | Intermediate Similarity | NPD4196 | Clinical (unspecified phase) |
0.7576 | Intermediate Similarity | NPD2797 | Approved |
0.7576 | Intermediate Similarity | NPD1203 | Approved |
0.7574 | Intermediate Similarity | NPD943 | Approved |
0.7556 | Intermediate Similarity | NPD3764 | Approved |
0.7542 | Intermediate Similarity | NPD289 | Clinical (unspecified phase) |
0.7518 | Intermediate Similarity | NPD230 | Phase 1 |
0.75 | Intermediate Similarity | NPD1759 | Phase 1 |
0.75 | Intermediate Similarity | NPD9545 | Approved |
0.7482 | Intermediate Similarity | NPD3299 | Clinical (unspecified phase) |
0.7482 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7482 | Intermediate Similarity | NPD2799 | Discontinued |
0.746 | Intermediate Similarity | NPD5951 | Approved |
0.7458 | Intermediate Similarity | NPD2066 | Phase 3 |
0.7447 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7445 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7426 | Intermediate Similarity | NPD3268 | Approved |
0.7422 | Intermediate Similarity | NPD1758 | Phase 1 |
0.7415 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7398 | Intermediate Similarity | NPD6831 | Clinical (unspecified phase) |
0.7388 | Intermediate Similarity | NPD2798 | Approved |
0.7385 | Intermediate Similarity | NPD4626 | Approved |
0.7385 | Intermediate Similarity | NPD3019 | Approved |
0.7385 | Intermediate Similarity | NPD2932 | Approved |
0.7379 | Intermediate Similarity | NPD2534 | Approved |
0.7379 | Intermediate Similarity | NPD2532 | Approved |
0.7379 | Intermediate Similarity | NPD2533 | Approved |
0.7368 | Intermediate Similarity | NPD9258 | Approved |
0.7368 | Intermediate Similarity | NPD1089 | Approved |
0.7368 | Intermediate Similarity | NPD1086 | Approved |
0.7368 | Intermediate Similarity | NPD9256 | Approved |
0.7368 | Intermediate Similarity | NPD1090 | Approved |
0.7368 | Intermediate Similarity | NPD1283 | Approved |
0.7343 | Intermediate Similarity | NPD7003 | Approved |
0.7328 | Intermediate Similarity | NPD845 | Approved |
0.731 | Intermediate Similarity | NPD7390 | Discontinued |
0.7305 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7302 | Intermediate Similarity | NPD7635 | Approved |
0.7299 | Intermediate Similarity | NPD2313 | Discontinued |
0.7297 | Intermediate Similarity | NPD3226 | Approved |
0.7281 | Intermediate Similarity | NPD800 | Approved |
0.7273 | Intermediate Similarity | NPD1929 | Approved |
0.7273 | Intermediate Similarity | NPD1930 | Approved |
0.7273 | Intermediate Similarity | NPD1931 | Clinical (unspecified phase) |
0.7265 | Intermediate Similarity | NPD1693 | Approved |
0.7246 | Intermediate Similarity | NPD520 | Approved |
0.7241 | Intermediate Similarity | NPD3300 | Phase 2 |
0.7241 | Intermediate Similarity | NPD1088 | Approved |
0.7222 | Intermediate Similarity | NPD3750 | Approved |
0.7222 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7218 | Intermediate Similarity | NPD1608 | Approved |
0.7214 | Intermediate Similarity | NPD1607 | Approved |
0.7213 | Intermediate Similarity | NPD164 | Approved |
0.72 | Intermediate Similarity | NPD1317 | Discontinued |
0.719 | Intermediate Similarity | NPD846 | Approved |
0.719 | Intermediate Similarity | NPD940 | Approved |
0.719 | Intermediate Similarity | NPD1932 | Approved |
0.7167 | Intermediate Similarity | NPD3020 | Approved |
0.7153 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7143 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD1281 | Approved |
0.7133 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7132 | Intermediate Similarity | NPD255 | Approved |
0.7132 | Intermediate Similarity | NPD256 | Approved |
0.7132 | Intermediate Similarity | NPD1019 | Discontinued |
0.7122 | Intermediate Similarity | NPD6663 | Approved |
0.7121 | Intermediate Similarity | NPD1778 | Approved |
0.7121 | Intermediate Similarity | NPD7163 | Clinical (unspecified phase) |
0.712 | Intermediate Similarity | NPD2182 | Approved |
0.712 | Intermediate Similarity | NPD2329 | Discontinued |
0.7119 | Intermediate Similarity | NPD1432 | Clinical (unspecified phase) |
0.7115 | Intermediate Similarity | NPD6232 | Discontinued |
0.7105 | Intermediate Similarity | NPD1087 | Approved |
0.7103 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7103 | Intermediate Similarity | NPD8166 | Discontinued |
0.7089 | Intermediate Similarity | NPD7473 | Discontinued |
0.708 | Intermediate Similarity | NPD5736 | Approved |
0.7071 | Intermediate Similarity | NPD1240 | Approved |
0.7068 | Intermediate Similarity | NPD3496 | Discontinued |
0.7067 | Intermediate Similarity | NPD7458 | Discontinued |
0.7063 | Intermediate Similarity | NPD3022 | Approved |
0.7063 | Intermediate Similarity | NPD6099 | Approved |
0.7063 | Intermediate Similarity | NPD3021 | Approved |
0.7063 | Intermediate Similarity | NPD6100 | Approved |
0.7059 | Intermediate Similarity | NPD3267 | Approved |
0.7059 | Intermediate Similarity | NPD3266 | Approved |
0.7054 | Intermediate Similarity | NPD690 | Clinical (unspecified phase) |
0.7045 | Intermediate Similarity | NPD5691 | Approved |
0.7037 | Intermediate Similarity | NPD1755 | Approved |
0.7034 | Intermediate Similarity | NPD5122 | Clinical (unspecified phase) |
0.7034 | Intermediate Similarity | NPD1202 | Approved |
0.7027 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7018 | Intermediate Similarity | NPD9259 | Approved |
0.7018 | Intermediate Similarity | NPD9257 | Approved |
0.7008 | Intermediate Similarity | NPD2181 | Clinical (unspecified phase) |
0.7007 | Intermediate Similarity | NPD257 | Approved |
0.7007 | Intermediate Similarity | NPD258 | Approved |
0.7007 | Intermediate Similarity | NPD6007 | Clinical (unspecified phase) |
0.6993 | Remote Similarity | NPD1510 | Phase 2 |
0.6992 | Remote Similarity | NPD17 | Approved |
0.6963 | Remote Similarity | NPD3972 | Approved |
0.696 | Remote Similarity | NPD1444 | Approved |
0.696 | Remote Similarity | NPD1445 | Approved |
0.6957 | Remote Similarity | NPD9494 | Approved |
0.6953 | Remote Similarity | NPD9508 | Approved |
0.695 | Remote Similarity | NPD2979 | Phase 3 |
0.694 | Remote Similarity | NPD3026 | Approved |
0.694 | Remote Similarity | NPD3023 | Approved |
0.6935 | Remote Similarity | NPD1237 | Approved |
0.6918 | Remote Similarity | NPD7421 | Clinical (unspecified phase) |
0.6917 | Remote Similarity | NPD1809 | Phase 2 |
0.6917 | Remote Similarity | NPD2859 | Approved |
0.6917 | Remote Similarity | NPD3025 | Approved |
0.6917 | Remote Similarity | NPD2860 | Approved |
0.6917 | Remote Similarity | NPD3024 | Approved |
0.6912 | Remote Similarity | NPD4749 | Approved |
0.6912 | Remote Similarity | NPD182 | Clinical (unspecified phase) |
0.6905 | Remote Similarity | NPD2342 | Discontinued |
0.6903 | Remote Similarity | NPD4868 | Clinical (unspecified phase) |
0.6897 | Remote Similarity | NPD2344 | Approved |
0.6883 | Remote Similarity | NPD7819 | Suspended |
0.6875 | Remote Similarity | NPD3748 | Approved |
0.6875 | Remote Similarity | NPD4141 | Clinical (unspecified phase) |
0.687 | Remote Similarity | NPD6671 | Approved |
0.6867 | Remote Similarity | NPD8150 | Discontinued |
0.6867 | Remote Similarity | NPD6273 | Approved |
0.6864 | Remote Similarity | NPD1239 | Approved |
0.6863 | Remote Similarity | NPD2672 | Discontinued |
0.686 | Remote Similarity | NPD1566 | Phase 3 |
0.686 | Remote Similarity | NPD1565 | Approved |
0.686 | Remote Similarity | NPD1564 | Approved |
0.6857 | Remote Similarity | NPD5952 | Clinical (unspecified phase) |
0.6839 | Remote Similarity | NPD2379 | Clinical (unspecified phase) |
0.6838 | Remote Similarity | NPD1481 | Phase 2 |
0.6833 | Remote Similarity | NPD2933 | Approved |
0.6833 | Remote Similarity | NPD2934 | Approved |
0.6831 | Remote Similarity | NPD825 | Approved |
0.6831 | Remote Similarity | NPD826 | Approved |
0.6824 | Remote Similarity | NPD6190 | Approved |
0.6822 | Remote Similarity | NPD1609 | Clinical (unspecified phase) |
0.6818 | Remote Similarity | NPD9568 | Approved |
0.6803 | Remote Similarity | NPD9495 | Approved |
0.68 | Remote Similarity | NPD5909 | Discontinued |
0.68 | Remote Similarity | NPD4378 | Clinical (unspecified phase) |
0.6797 | Remote Similarity | NPD1792 | Phase 2 |
0.6797 | Remote Similarity | NPD6599 | Discontinued |
0.6795 | Remote Similarity | NPD7768 | Phase 2 |
0.6794 | Remote Similarity | NPD2629 | Approved |
0.6791 | Remote Similarity | NPD1651 | Approved |
0.679 | Remote Similarity | NPD5844 | Phase 1 |
0.6783 | Remote Similarity | NPD6355 | Discontinued |
0.6781 | Remote Similarity | NPD6003 | Clinical (unspecified phase) |
0.6781 | Remote Similarity | NPD6006 | Clinical (unspecified phase) |
0.6781 | Remote Similarity | NPD6002 | Phase 3 |
0.6781 | Remote Similarity | NPD6005 | Phase 3 |
0.6781 | Remote Similarity | NPD6004 | Phase 3 |
0.6779 | Remote Similarity | NPD6884 | Clinical (unspecified phase) |
0.6776 | Remote Similarity | NPD2370 | Clinical (unspecified phase) |
0.6774 | Remote Similarity | NPD1465 | Phase 2 |
0.6769 | Remote Similarity | NPD5277 | Phase 2 |
0.6765 | Remote Similarity | NPD422 | Phase 1 |
0.6765 | Remote Similarity | NPD1611 | Approved |
0.6765 | Remote Similarity | NPD1535 | Discovery |
0.6757 | Remote Similarity | NPD1196 | Approved |
0.6754 | Remote Similarity | NPD9491 | Approved |
0.6752 | Remote Similarity | NPD3749 | Approved |
0.6741 | Remote Similarity | NPD1362 | Clinical (unspecified phase) |
0.6739 | Remote Similarity | NPD1876 | Approved |
0.6739 | Remote Similarity | NPD3225 | Approved |
PubChem CID   | 25775004 |
ChEMBL   | CHEMBL2361427 |
ZINC   |
Molecular Weight:   | 266.15 |
ALogP:   | -0.2097 |
MLogP:   | 2.67 |
XLogP:   | 3.929 |
# Rotatable Bonds:   | 12 |
Polar Surface Area:   | 77.76 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 3 |
# Rings:   | 1 |
# Heavy Atoms:   | 19 |